{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:43:44Z","timestamp":1794012224452,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10549-018-4726-x","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T06:11:42Z","timestamp":1519279902000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Screening of over 1000 Indian patients with breast and\/or ovarian cancer with a multi-gene panel: prevalence of BRCA1\/2 and non-BRCA mutations"],"prefix":"10.1007","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5949-9254","authenticated-orcid":false,"given":"Jaya","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishita","family":"Thota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhasini","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shila","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Deshwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumit","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithua","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosina","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Almel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basumita","family":"Chakraborti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen K.","family":"DadiReddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. K.","family":"Smruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil","family":"Rajappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandragouda","family":"Dodagoudar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajai","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarati","family":"Karaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Sankaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmukh","family":"Katragadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunabha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi","family":"Veeramachaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Hariharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf U.","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"4726_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130. \n                    https:\/\/doi.org\/10.1086\/375033","journal-title":"Am J Hum Genet"},{"key":"4726_CR2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329\u20131333. \n                    https:\/\/doi.org\/10.1200\/JCO.2006.09.1066","journal-title":"J Clin Oncol"},{"key":"4726_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","volume":"17","author":"SE Lincoln","year":"2015","unstructured":"Lincoln SE, Kobayashi Y, Anderson MJ et al (2015) A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. J Mol Diagn 17:533\u2013544. \n                    https:\/\/doi.org\/10.1016\/j.jmoldx.2015.04.009","journal-title":"J Mol Diagn"},{"key":"4726_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","volume":"1","author":"A Desmond","year":"2015","unstructured":"Desmond A, Kurian AW, Gabree M et al (2015) Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol 1:943\u2013951. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2015.2690","journal-title":"JAMA Oncol"},{"key":"4726_CR5","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A et al (2017) A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 123:1721\u20131730. \n                    https:\/\/doi.org\/10.1002\/cncr.30498","journal-title":"Cancer"},{"key":"4726_CR6","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.18632\/oncotarget.12699","volume":"8","author":"M Eliade","year":"2017","unstructured":"Eliade M, Skrzypski J, Baurand A et al (2017) The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: what are the implications for the management of patients and families? Oncotarget 8:1957\u20131971. \n                    https:\/\/doi.org\/10.18632\/oncotarget.12699","journal-title":"Oncotarget"},{"key":"4726_CR7","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","volume":"22","author":"L Cast\u00e9ra","year":"2014","unstructured":"Cast\u00e9ra L, Krieger S, Rousselin A et al (2014) Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet 22:1305\u20131313. \n                    https:\/\/doi.org\/10.1038\/ejhg.2014.16","journal-title":"Eur J Hum Genet"},{"key":"4726_CR8","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J et al (2016) Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34:1460\u20131468. \n                    https:\/\/doi.org\/10.1200\/JCO.2015.65.0747","journal-title":"J Clin Oncol"},{"key":"4726_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0424","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C et al (2017) Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2017.0424","journal-title":"JAMA Oncol"},{"key":"4726_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R et al (2016) Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med 18:823\u2013832. \n                    https:\/\/doi.org\/10.1038\/gim.2015.166","journal-title":"Genet Med"},{"key":"4726_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/gim.2015.212","volume":"18","author":"BH Shirts","year":"2016","unstructured":"Shirts BH, Casadei S, Jacobson AL et al (2016) Improving performance of multigene panels for genomic analysis of cancer predisposition. Genet Med 18:1\u20138. \n                    https:\/\/doi.org\/10.1038\/gim.2015.212","journal-title":"Genet Med"},{"key":"4726_CR12","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PDP, Antoniou AC et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372:2243\u20132257. \n                    https:\/\/doi.org\/10.1056\/NEJMsr1501341","journal-title":"N Engl J Med"},{"key":"4726_CR13","unstructured":"National Comprehensive Cancer Network (NCCN) (2016) Genetic\/Familial High-Risk Assessment\u202f: Breast and Ovarian, Version 2. 2017. In: NCCN. \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/genetics_screening.pdf\n                    \n                  . Accessed 24 Apr 2017"},{"key":"4726_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2007.01.010","volume":"11","author":"T Walsh","year":"2007","unstructured":"Walsh T, King M-C (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103\u2013105. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2007.01.010","journal-title":"Cancer Cell"},{"key":"4726_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00439-008-0529-1","volume":"124","author":"PM Campeau","year":"2008","unstructured":"Campeau PM, Foulkes WD, Tischkowitz MD (2008) Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124:31\u201342. \n                    https:\/\/doi.org\/10.1007\/s00439-008-0529-1","journal-title":"Hum Genet"},{"key":"4726_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108. \n                    https:\/\/doi.org\/10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"key":"4726_CR17","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00438-016-1239-3","volume":"291","author":"G Singh","year":"2016","unstructured":"Singh G, Talwar I, Sharma R et al (2016) Genetic differentiation and population structure of five ethnic groups of Punjab (North-West India). Mol Genet Genomics 291:2055\u20132063. \n                    https:\/\/doi.org\/10.1007\/s00438-016-1239-3","journal-title":"Mol Genet Genomics"},{"key":"4726_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2350-7-75","volume":"7","author":"S Saxena","year":"2006","unstructured":"Saxena S, Chakraborty A, Kaushal M et al (2006) Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet 7:75. \n                    https:\/\/doi.org\/10.1186\/1471-2350-7-75","journal-title":"BMC Med Genet"},{"key":"4726_CR19","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.7314\/APJCP.2015.16.13.5211","volume":"16","author":"T Rajkumar","year":"2015","unstructured":"Rajkumar T, Meenakumari B, Mani S et al (2015) Targeted resequencing of 30 genes improves the detection of deleterious mutations in south indian women with breast and\/or ovarian cancers. Asian Pac J Cancer Prev 16:5211\u20135217","journal-title":"Asian Pac J Cancer Prev"},{"key":"4726_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/jhg.2016.4","volume":"61","author":"AU Mannan","year":"2016","unstructured":"Mannan AU, Singh J, Lakshmikeshava R et al (2016) Detection of high frequency of mutations in a breast and\/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India. J Hum Genet 61:515\u2013522. \n                    https:\/\/doi.org\/10.1038\/jhg.2016.4","journal-title":"J Hum Genet"},{"key":"4726_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jmoldx.2016.07.006","volume":"18","author":"W Mu","year":"2016","unstructured":"Mu W, Lu H-M, Chen J et al (2016) Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing. J Mol Diagn 18:923\u2013932. \n                    https:\/\/doi.org\/10.1016\/j.jmoldx.2016.07.006","journal-title":"J Mol Diagn"},{"key":"4726_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jmoldx.2015.03.004","volume":"17","author":"LM Baudhuin","year":"2015","unstructured":"Baudhuin LM, Lagerstedt SA, Klee EW et al (2015) Confirming variants in next-generation sequencing panel testing by Sanger sequencing. J Mol Diagn 17:456\u2013461. \n                    https:\/\/doi.org\/10.1016\/j.jmoldx.2015.03.004","journal-title":"J Mol Diagn"},{"key":"4726_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2307\/1390807","volume":"5","author":"R Ihaka","year":"1996","unstructured":"Ihaka R, Gentleman R (1996) R: a language for data analysis and graphics. J Comput Graph Stat 5:299\u2013314. \n                    https:\/\/doi.org\/10.2307\/1390807","journal-title":"J Comput Graph Stat"},{"key":"4726_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000115288","volume":"3","author":"G Agarwal","year":"2008","unstructured":"Agarwal G, Ramakant P (2008) Breast cancer care in india: the current scenario and the challenges for the future. Breast Care 3:21\u201327. \n                    https:\/\/doi.org\/10.1159\/000115288","journal-title":"Breast Care"},{"key":"4726_CR25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00268-005-0585-9","volume":"31","author":"G Agarwal","year":"2007","unstructured":"Agarwal G, Pradeep PV, Aggarwal V et al (2007) Spectrum of breast cancer in Asian women. World J Surg 31:1031\u20131040. \n                    https:\/\/doi.org\/10.1007\/s00268-005-0585-9","journal-title":"World J Surg"},{"key":"4726_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ejhg.2012.124","volume":"21","author":"Y Laitman","year":"2013","unstructured":"Laitman Y, Feng B-J, Zamir IM et al (2013) Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations. Eur J Hum Genet 21:212\u2013216. \n                    https:\/\/doi.org\/10.1038\/ejhg.2012.124","journal-title":"Eur J Hum Genet"},{"key":"4726_CR27","first-page":"1166","volume":"58","author":"DB Berman","year":"1996","unstructured":"Berman DB, Wagner-Costalas J, Schultz DC et al (1996) Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 58:1166\u20131176","journal-title":"Am J Hum Genet"},{"key":"4726_CR28","doi-asserted-by":"publisher","first-page":"928562","DOI":"10.1155\/2013\/928562","volume":"2013","author":"F Karami","year":"2013","unstructured":"Karami F, Mehdipour P (2013) A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res Int 2013:928562. \n                    https:\/\/doi.org\/10.1155\/2013\/928562","journal-title":"Biomed Res Int"},{"key":"4726_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10549-004-0593-8","volume":"88","author":"S Hedau","year":"2004","unstructured":"Hedau S, Jain N, Husain SA et al (2004) Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res Treat 88:177\u2013186. \n                    https:\/\/doi.org\/10.1007\/s10549-004-0593-8","journal-title":"Breast Cancer Res Treat"},{"key":"4726_CR30","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1002\/ijc.30633","volume":"140","author":"T Shi","year":"2017","unstructured":"Shi T, Wang P, Xie C et al (2017) BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer. Int J Cancer 140:2051\u20132059. \n                    https:\/\/doi.org\/10.1002\/ijc.30633","journal-title":"Int J Cancer"},{"key":"4726_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12916-015-0425-1","volume":"13","author":"L Livraghi","year":"2015","unstructured":"Livraghi L, Garber JE (2015) PARP inhibitors in the management of breast cancer: current data and future prospects. BMC Med 13:188. \n                    https:\/\/doi.org\/10.1186\/s12916-015-0425-1","journal-title":"BMC Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4726-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4726-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4726-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T20:28:29Z","timestamp":1550780909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4726-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4726"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4726-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]},"assertion":[{"value":"16 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The datasets used and\/or analyzed during the current study are available from the corresponding author on request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experiments performed in this study comply with the current laws of ethical guidelines for clinical research in India.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects and sequencing of patient samples was approved by Institutional Ethics Committee of Strand Life Sciences, Bangalore, India. This study was funded by institutional internal fund.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}